Closer to a change in the first line of treatment. 80 percent of patients are diagnosed in advanced stage.
The latest edition of ESMO for gynecological cancer is being a separate point for the therapeutic approach to ovarian cancer. Gaceta Médica.
https://www.recercasantpau.cat/wp-content/uploads/2019/10/Recerca_Gaceta-Medica-14102019-1.pdf
